Basic and Diluted Net Loss Per Share (Details) - Schedule of anti-dilutive effect - shares	3 Months Ended	9 Months Ended	12 Months Ended
Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020	Dec. 31, 2019
Schedule of anti-dilutive effect [Abstract]
Warrants	9,548,518	8,717,239	10,755,971	8,717,239	9,484,134	4,387,223

Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 40
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=125511455&loc=d3e2029-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration